ROWLAND LLOYD A
SEC CIK 1236395 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | GC | 120.6K | — | $47.0K | 14 | 2022-02-02 | 2025-03-18 |
Most active insiders at CTMX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | McCarthy Sean A. | CEO, Dir | — | $1.23M |
| 2 | BELVIN MARCIA | SVP, CSO | — | $202.2K |
| 3 | Chu Yu-Waye | Chief Medical Off | — | $136.6K |
| 4 | Ogden Christopher | CFO | — | $129.0K |
| 5 | Lester Rachael | Chief Business Off | — | — |
| 6 | Carvajal Alejandra | CLO | — | — |
ROWLAND LLOYD A made no open-market trades at CTMX in the last 12 months.
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-20 | 2025-03-18 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | S - Sale | $0.6 | -10.2K | 120.6K | -8% | -$6,122 | |
| D | 2024-08-22 | 2024-08-20 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | M - OptEx | $0.00 | +11.2K | 135.0K | +9% | $0 |
| D | 2024-08-22 | 2024-08-20 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | S - Sale+OE | $1.23 | -4,181 | 130.8K | -3% | -$5,143 |
| 2024-03-21 | 2024-03-19 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | S - Sale | $2.09 | -5,268 | 117.7K | -4% | -$11.0K | |
| D | 2024-01-19 | 2024-01-18 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | A - Grant | $0.00 | +25.0K | 123.0K | +26% | $0 |
| 2023-12-22 | 2023-12-20 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | S - Sale | $1.38 | -4,077 | 98.0K | -4% | -$5,626 | |
| D | 2023-12-19 | 2023-12-17 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | M - OptEx | $0.00 | +11.2K | 102.1K | +12% | $0 |
| 2023-09-22 | 2023-09-22 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | S - Sale | $1.30 | -5,486 | 80.6K | -6% | -$7,132 | |
| 2023-09-22 | 2023-09-20 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | A - Grant | $0.00 | +15.0K | 86.1K | +21% | $0 | |
| 2023-03-20 | 2023-03-16 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | S - Sale | $1.98 | -2,037 | 71.1K | -3% | -$4,033 | |
| D | 2023-02-06 | 2023-02-02 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | A - Grant | $0.00 | +25.0K | 73.1K | +52% | $0 |
| 2022-07-21 | 2022-07-19 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | A - Grant | $0.00 | +15.0K | 49.3K | +44% | $0 | |
| 2022-07-21 | 2022-07-20 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | S - Sale | $1.42 | -5,602 | 43.7K | -11% | -$7,955 | |
| D | 2022-02-04 | 2022-02-02 | CTMX | CytomX Therapeutics, Inc. | ROWLAND LLOYD A | GC | A - Grant | $0.00 | +22.5K | 34.3K | +191% | $0 |
Purchase Sale Sale after option exercise All abbreviations